FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve

Detalhes bibliográficos
Autor(a) principal: Rehnitz, Julia
Data de Publicação: 2018
Outros Autores: Alcoba, Diego Duarte, Brum, Ilma Simoni, Dietrich, Jens Erik, Youness, Berthe, Hinderhofer, Katrin, Messmer, Birgitta, Freis, Alexander, Strowitzki, Thomas, Germeyer, Ariane
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/193532
Resumo: Background: Fragile-X-Mental-Retardation-1- (FMR1)-gene is supposed to be a key gene for ovarian reserve and folliculogenesis. It contains in its 5’-UTR a triplet-base-repeat (CGG), that varies between 26 and 34 in general population. CGG-repeat-lengths with 55–200 repeats (pre-mutation = PM) show instable heredity with a tendency to increase and are associated with premature-ovarian-insufficiency or failure (POI/POF) in about 20%. FMR1-mRNA-expression in leucocytes and granulosa cells (GCs) increases with CGG-repeat-length in PM-carriers, but variable FMR1-expression profiles were also described in women with POI without PM-FMR1 repeat-length. Additionally, associations between low numbers of retrieved oocytes and elevated FMR1-expression levels have been shown in GCs of females with mid-range PM-CGG-repeats without POI. Effects of FMR1-repeat-lengths-deviations (n < 26 or n > 34) below the PM range (n < 55) on ovarian reserve and response to ovarian stimulation remain controversial. Methods: We enrolled 229 women undergoing controlled ovarian hyperstimulation for IVF/ICSI-treatment and devided them in three ovarian-response-subgroups: Poor responder (POR) after Bologna Criteria, polycystic ovary syndrome (PCO) after Rotterdam Criteria, or normal responder (NOR, control group). Subjects were subdivided into six genotypes according to their be-allelic CGG-repeat length. FMR1-CGG-repeat-length was determined using ALF-express-DNA-sequencer or ABI 3100/3130 × 1-sequencer. mRNA was extracted from GCs after follicular aspiration and quantitative FMR1-expression was determined using specific TaqMan-Assay and applying the ΔΔCT method. Kruskall-Wallis-Test or ANOVA were used for simple comparison between ovarian reserve (NOR, POR or PCO) and CGG-subgroups or cohort demographic data. All statistical analysis were performed with SPSS and statistical significance was set at p ≤ 0.05. Results: A statistically significant increase in FMR1-mRNA-expression-levels was detected in GCs of PORs with heterozygous normal/low-CGG-repeat-length compared with other genotypes (p = 0.044). Conclusion: Female ovarian response may be negatively affected by low CGG-alleles during stimulation. In addition, due to a low-allele-effect, folliculogenesis may be impaired already prior to stimulation leading to diminished ovarian reserve and poor ovarian response. A better understanding of FMR1 expression-regulation in GCs may help to elucidate pathomechanisms of folliculogenesis disorders and to develop risk-adjusted treatments for IVF/ICSI-therapy. Herewith FMR1-genotyping potentially provides a better estimatation of treatment outcome and allows the optimal adaptation of stimulation protocols in future.
id UFRGS-2_2de7630fab129a0924b1df0c9979f6ef
oai_identifier_str oai:www.lume.ufrgs.br:10183/193532
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Rehnitz, JuliaAlcoba, Diego DuarteBrum, Ilma SimoniDietrich, Jens ErikYouness, BertheHinderhofer, KatrinMessmer, BirgittaFreis, AlexanderStrowitzki, ThomasGermeyer, Ariane2019-04-26T02:38:15Z20181477-7827http://hdl.handle.net/10183/193532001074897Background: Fragile-X-Mental-Retardation-1- (FMR1)-gene is supposed to be a key gene for ovarian reserve and folliculogenesis. It contains in its 5’-UTR a triplet-base-repeat (CGG), that varies between 26 and 34 in general population. CGG-repeat-lengths with 55–200 repeats (pre-mutation = PM) show instable heredity with a tendency to increase and are associated with premature-ovarian-insufficiency or failure (POI/POF) in about 20%. FMR1-mRNA-expression in leucocytes and granulosa cells (GCs) increases with CGG-repeat-length in PM-carriers, but variable FMR1-expression profiles were also described in women with POI without PM-FMR1 repeat-length. Additionally, associations between low numbers of retrieved oocytes and elevated FMR1-expression levels have been shown in GCs of females with mid-range PM-CGG-repeats without POI. Effects of FMR1-repeat-lengths-deviations (n < 26 or n > 34) below the PM range (n < 55) on ovarian reserve and response to ovarian stimulation remain controversial. Methods: We enrolled 229 women undergoing controlled ovarian hyperstimulation for IVF/ICSI-treatment and devided them in three ovarian-response-subgroups: Poor responder (POR) after Bologna Criteria, polycystic ovary syndrome (PCO) after Rotterdam Criteria, or normal responder (NOR, control group). Subjects were subdivided into six genotypes according to their be-allelic CGG-repeat length. FMR1-CGG-repeat-length was determined using ALF-express-DNA-sequencer or ABI 3100/3130 × 1-sequencer. mRNA was extracted from GCs after follicular aspiration and quantitative FMR1-expression was determined using specific TaqMan-Assay and applying the ΔΔCT method. Kruskall-Wallis-Test or ANOVA were used for simple comparison between ovarian reserve (NOR, POR or PCO) and CGG-subgroups or cohort demographic data. All statistical analysis were performed with SPSS and statistical significance was set at p ≤ 0.05. Results: A statistically significant increase in FMR1-mRNA-expression-levels was detected in GCs of PORs with heterozygous normal/low-CGG-repeat-length compared with other genotypes (p = 0.044). Conclusion: Female ovarian response may be negatively affected by low CGG-alleles during stimulation. In addition, due to a low-allele-effect, folliculogenesis may be impaired already prior to stimulation leading to diminished ovarian reserve and poor ovarian response. A better understanding of FMR1 expression-regulation in GCs may help to elucidate pathomechanisms of folliculogenesis disorders and to develop risk-adjusted treatments for IVF/ICSI-therapy. Herewith FMR1-genotyping potentially provides a better estimatation of treatment outcome and allows the optimal adaptation of stimulation protocols in future.application/pdfengReproductive biology and endocrinology. London. Vol. 16 (2018), 65, [9 p.]Insuficiência ovariana primáriaCélulas da granulosaHormônio folículo estimulanteFMR1 expressionGranulosa cellsFMR1 CGG repeat lengthFMR1 genotypeFMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserveEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001074897.pdf.txt001074897.pdf.txtExtracted Texttext/plain47817http://www.lume.ufrgs.br/bitstream/10183/193532/2/001074897.pdf.txt294db414ee2a9fe48c3e83d367614625MD52ORIGINAL001074897.pdfTexto completo (inglês)application/pdf626737http://www.lume.ufrgs.br/bitstream/10183/193532/1/001074897.pdf76116507ee465c6b3872dbd1d322da27MD5110183/1935322019-04-27 02:37:29.367297oai:www.lume.ufrgs.br:10183/193532Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2019-04-27T05:37:29Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
title FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
spellingShingle FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
Rehnitz, Julia
Insuficiência ovariana primária
Células da granulosa
Hormônio folículo estimulante
FMR1 expression
Granulosa cells
FMR1 CGG repeat length
FMR1 genotype
title_short FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
title_full FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
title_fullStr FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
title_full_unstemmed FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
title_sort FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
author Rehnitz, Julia
author_facet Rehnitz, Julia
Alcoba, Diego Duarte
Brum, Ilma Simoni
Dietrich, Jens Erik
Youness, Berthe
Hinderhofer, Katrin
Messmer, Birgitta
Freis, Alexander
Strowitzki, Thomas
Germeyer, Ariane
author_role author
author2 Alcoba, Diego Duarte
Brum, Ilma Simoni
Dietrich, Jens Erik
Youness, Berthe
Hinderhofer, Katrin
Messmer, Birgitta
Freis, Alexander
Strowitzki, Thomas
Germeyer, Ariane
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rehnitz, Julia
Alcoba, Diego Duarte
Brum, Ilma Simoni
Dietrich, Jens Erik
Youness, Berthe
Hinderhofer, Katrin
Messmer, Birgitta
Freis, Alexander
Strowitzki, Thomas
Germeyer, Ariane
dc.subject.por.fl_str_mv Insuficiência ovariana primária
Células da granulosa
Hormônio folículo estimulante
topic Insuficiência ovariana primária
Células da granulosa
Hormônio folículo estimulante
FMR1 expression
Granulosa cells
FMR1 CGG repeat length
FMR1 genotype
dc.subject.eng.fl_str_mv FMR1 expression
Granulosa cells
FMR1 CGG repeat length
FMR1 genotype
description Background: Fragile-X-Mental-Retardation-1- (FMR1)-gene is supposed to be a key gene for ovarian reserve and folliculogenesis. It contains in its 5’-UTR a triplet-base-repeat (CGG), that varies between 26 and 34 in general population. CGG-repeat-lengths with 55–200 repeats (pre-mutation = PM) show instable heredity with a tendency to increase and are associated with premature-ovarian-insufficiency or failure (POI/POF) in about 20%. FMR1-mRNA-expression in leucocytes and granulosa cells (GCs) increases with CGG-repeat-length in PM-carriers, but variable FMR1-expression profiles were also described in women with POI without PM-FMR1 repeat-length. Additionally, associations between low numbers of retrieved oocytes and elevated FMR1-expression levels have been shown in GCs of females with mid-range PM-CGG-repeats without POI. Effects of FMR1-repeat-lengths-deviations (n < 26 or n > 34) below the PM range (n < 55) on ovarian reserve and response to ovarian stimulation remain controversial. Methods: We enrolled 229 women undergoing controlled ovarian hyperstimulation for IVF/ICSI-treatment and devided them in three ovarian-response-subgroups: Poor responder (POR) after Bologna Criteria, polycystic ovary syndrome (PCO) after Rotterdam Criteria, or normal responder (NOR, control group). Subjects were subdivided into six genotypes according to their be-allelic CGG-repeat length. FMR1-CGG-repeat-length was determined using ALF-express-DNA-sequencer or ABI 3100/3130 × 1-sequencer. mRNA was extracted from GCs after follicular aspiration and quantitative FMR1-expression was determined using specific TaqMan-Assay and applying the ΔΔCT method. Kruskall-Wallis-Test or ANOVA were used for simple comparison between ovarian reserve (NOR, POR or PCO) and CGG-subgroups or cohort demographic data. All statistical analysis were performed with SPSS and statistical significance was set at p ≤ 0.05. Results: A statistically significant increase in FMR1-mRNA-expression-levels was detected in GCs of PORs with heterozygous normal/low-CGG-repeat-length compared with other genotypes (p = 0.044). Conclusion: Female ovarian response may be negatively affected by low CGG-alleles during stimulation. In addition, due to a low-allele-effect, folliculogenesis may be impaired already prior to stimulation leading to diminished ovarian reserve and poor ovarian response. A better understanding of FMR1 expression-regulation in GCs may help to elucidate pathomechanisms of folliculogenesis disorders and to develop risk-adjusted treatments for IVF/ICSI-therapy. Herewith FMR1-genotyping potentially provides a better estimatation of treatment outcome and allows the optimal adaptation of stimulation protocols in future.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2019-04-26T02:38:15Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/193532
dc.identifier.issn.pt_BR.fl_str_mv 1477-7827
dc.identifier.nrb.pt_BR.fl_str_mv 001074897
identifier_str_mv 1477-7827
001074897
url http://hdl.handle.net/10183/193532
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Reproductive biology and endocrinology. London. Vol. 16 (2018), 65, [9 p.]
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/193532/2/001074897.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/193532/1/001074897.pdf
bitstream.checksum.fl_str_mv 294db414ee2a9fe48c3e83d367614625
76116507ee465c6b3872dbd1d322da27
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224964440850432